Academic Partners

Dennis J. Slamon MD, Ph.D.

Collaboration with Dr. Slamon at the University of California, Los Angeles, to explore potential clinical indications in breast cancer for a number of Zymeworks' bi-specific antibodies.


Martin J. Boulanger Ph.D.

Collaboration with Professor Boulanger, Assistant Professor of Biochemistry & Microbiology at the University of Victoria, Canada, to use X-ray crystallography to better understand the structure-function relationships between therapeutic antibodies and disease targets.